# Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

> **NCT03023566** · — · COMPLETED · sponsor: **Phoenix Children's Hospital** · enrollment: 250 (actual)

## Conditions studied

- Brain Diseases

## Interventions

- **DRUG:** Dotarem

## Key facts

- **NCT ID:** NCT03023566
- **Lead sponsor:** Phoenix Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-09
- **Primary completion:** 2017-11-12
- **Final completion:** 2017-11-12
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2022-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03023566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03023566, "Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03023566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*